After lynching spree in India, WhatsApp offers tips to spot fake news

Udupi, Jan 25: The accused, who planted a crude bomb at the Mangalore International Airport on January 20, was brought to Udupi on Saturday, to collect information, as part of the spot investigation, police said here.

According to police officials, accused Aditya Rao was brought to Karnataka Bank Kadiyali branch, where Rao had a Safe Locker. The team opened the locker and seized the documents, along with a Box.

They said the seized documents, along with the Box, will be sent to the FSL for investigation.

Mangaluru, Jan 3: Mangaluru police arrested another person on charge of spreading communal hatred through messages. The accused have been identified as Abubakkar Siddique (48).

"One Abubakkar Siddique has been arrested in connection with a case for spreading communal hatred through inciting messages," said Dr PS Harsha, commissioner of police, Mangaluru.

On December 31, Police have arrested one person, Moideen Hameez, on charge of spreading communal hatred through social media.

The Mangaluru city police on Monday served notices to a few persons for posting inflammatory messages on social media.

The Cyber Crime police have summoned the accused persons to appear before it on January 2.

"Action against miscreants spreading communal hatred on social media underway in a major way. A dedicated team of cyber experts is keeping a hawk's eye on anyone fomenting communal disharmony anywhere on the internet," Harsha said in another tweet.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.